Cargando…

Analysis of Suspension of Clinical Trials for Drug Registration in China

Suspension is an important risk control measure during clinical trials. We investigated the use of this in China and identified common reasons for suspension by analyzing trends, hold issues, outcomes, background and design characteristics of suspended clinical drug trials from January 1, 2013 to De...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Xian, Pang, Xiaocong, Zeng, Xin, Gao, Yi, Cui, Yimin, Wang, Haixue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277236/ https://www.ncbi.nlm.nih.gov/pubmed/34267651 http://dx.doi.org/10.3389/fphar.2020.598574

Ejemplares similares

Clinical Trial Registration and Reporting: Drug Therapy and Prevention of Cardiac-Related Infections
por: Ma, Lin-Lu, et al.
Publicado: (2019)

Biologics for Non-Cancer Dermatological Diseases: Analysis on China’s Clinical Trial Registration Trend From 2016 to 2020
por: Zhu, Beibei, et al.
Publicado: (2022)

Comprehensive Survey of Clinical Trials Registration for Melanoma Immunotherapy in the ClinicalTrials.gov
por: Wang, Yan-Bo, et al.
Publicado: (2020)

Trends in innovative pediatric drug development in China based on clinical trial registration data
por: Wu, Wen-Wen, et al.
Publicado: (2023)

Editorial: Data mining and network-driven analysis: Drug discovery and mechanism exploration by targeting vascular dysfunction
por: Dai, Zhao, et al.
Publicado: (2022)

Risk of venous thromboembolism with janus kinase inhibitors in inflammatory immune diseases: a systematic review and meta-analysis
por: Zhang, Juqi, et al.
Publicado: (2023)

Clinical Trials Focusing on Drug Control and Prevention of Ventilator-Associated Pneumonia: A Comprehensive Analysis of Trials Registered on ClinicalTrials.gov
por: Chen, Lingmin, et al.
Publicado: (2019)

China’s drug clinical trial institution record-keeping system: Qualification requirements for PI are the key
por: Huang, Nanqu, et al.
Publicado: (2023)

Analysis of the WHO ICTRP for novel coronavirus clinical trial registrations
por: Song, Gao, et al.
Publicado: (2020)

Analysis of drug resistance in pulmonary tuberculosis patients with positive sputum tuberculosis culture in Northeast China
por: Sichen, Li, et al.
Publicado: (2023)

Medical image registration utilizing tissue P systems
por: Kujur, Saleem Sanatan, et al.
Publicado: (2022)

The Efficacy of Berberine-Containing Quadruple Therapy on Helicobacter Pylori Eradication in China: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Hu, Qian, et al.
Publicado: (2020)

The Characteristics, Prevalence, and Risk Factors of Drug-Induced Liver Injury Among Brucellosis Inpatients in Xinjiang, China
por: Tuohutaerbieke, Maermaer, et al.
Publicado: (2021)

Metabolomic and lipidomic studies on the intervention of taurochenodeoxycholic acid in mice with hyperlipidemia
por: Cui, Na, et al.
Publicado: (2023)

Overexpression of Activating Transcription Factor 3 Alleviates Cardiac Microvascular Ischemia/Reperfusion Injury in Rats
por: Liu, Yi, et al.
Publicado: (2021)

Antidepressant-like drug effects in juvenile and adolescent mice in the tail suspension test: Relationship with hippocampal serotonin and norepinephrine transporter expression and function
por: Mitchell, Nathan C., et al.
Publicado: (2013)

Pharmacokinetic Characteristics of Siponimod in Healthy Volunteers and Patients With Multiple Sclerosis: Analyses of Published Clinical Trials
por: Chaoyang, Chen, et al.
Publicado: (2022)

Bioequivalence evaluation of two 5% ceftiofur hydrochloride sterile suspension in pigs
por: XIONG, Jincheng, et al.
Publicado: (2018)

Risk of infection in roxadustat treatment for anemia in patients with chronic kidney disease: A systematic review with meta-analysis and trial sequential analysis
por: Chong, Shan, et al.
Publicado: (2022)

Can Intraoperative Low-Dose R,S-Ketamine Prevent Depressive Symptoms After Surgery? The First Meta-Analysis of Clinical Trials
por: Pang, Liwei, et al.
Publicado: (2020)

The NPC1L1 Gene Exerts a Notable Impact on the Reduction of Low-Density Lipoprotein Cholesterol in Response to Hyzetimibe: A Factorial-Designed Clinical Trial
por: Liao, Jianwei, et al.
Publicado: (2022)

Registered Clinical Trials Comprising Pregnant Women in China: A Cross-Sectional Study
por: Zhao, Yi, et al.
Publicado: (2022)

Molecular Mechanisms of Action of Emodin: As an Anti-Cardiovascular Disease Drug
por: Li, Qianqian, et al.
Publicado: (2020)

Comprehensive Metabolomics and Network Pharmacology to Explore the Mechanism of 5-Hydroxymethyl Furfural in the Treatment of Blood Deficiency Syndrome
por: Zhang, Wensen, et al.
Publicado: (2022)

Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects
por: Pauli, Christopher S., et al.
Publicado: (2020)

A Database of Drug Repurposing Clinical Trials in Oncology
por: Pantziarka, Pan, et al.
Publicado: (2021)

Editorial: Clinical trials in drug metabolism and transport: 2022
por: Lai, Yurong, et al.
Publicado: (2023)

Analysis of new drug registration and review in China in 2021
por: Hu, Hongxi, et al.
Publicado: (2022)

Clinical Trials Registration
por: Rockhold, Frank W, et al.
Publicado: (2006)

Clinical trials registration
por: Tiffin, Norman H, et al.
Publicado: (2013)

Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
por: Dahlén, Amelia D., et al.
Publicado: (2022)

Therapeutic Drug Monitoring and Pharmacogenetic Testing in Northern China
por: Zhang, Chunyan, et al.
Publicado: (2021)

Innovation in Informatics to Improve Clinical Care and Drug Accessibility for Rare Diseases in China
por: Liu, Peng, et al.
Publicado: (2021)

The international clinical trials registry platform (ICTRP): data integrity and the trends in clinical trials, diseases, and drugs
por: Namiot, Eugenia D., et al.
Publicado: (2023)

Characteristics of COVID-19 Clinical Trials in China Based on the Registration Data on ChiCTR and ClinicalTrials.gov
por: Huang, Jihan, et al.
Publicado: (2020)

Efficacy, Safety and Mechanism of Jinzhen Oral Liquid in the Treatment of Acute Bronchitis in Children: A Randomized, Double-Blind, Multicenter Clinical Trial Protocol
por: Cui, Xin, et al.
Publicado: (2022)

The change of drug utilization in China’s public healthcare institutions under the “4 + 7” centralized drug procurement policy: Evidence from a natural experiment in China
por: Lu, Jiancheng, et al.
Publicado: (2022)

Hematologic side effects of immune checkpoint inhibitor with or without chemotherapy in patients with advanced and metastatic gastrointestinal cancer: A systematic review and network meta-analysis of phase 3 trials
por: Hou, Jingyi, et al.
Publicado: (2023)

Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
por: Li, Guangyao, et al.
Publicado: (2022)

Biocompatible Colloidal Suspensions Based on Magnetic Iron Oxide Nanoparticles: Synthesis, Characterization and Toxicological Profile
por: Coricovac, Dorina-Elena, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o82l5v4fo4uevr08jjemi6psov